Cowen Prime Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$8.12K Hold
220
﹤0.01% 171
2023
Q1
$6K Hold
220
﹤0.01% 179
2022
Q4
$7K Buy
+220
New +$6.6K ﹤0.01% 170
2018
Q4
Sell
-100
Closed -$4K 188
2018
Q3
$4K Hold
100
﹤0.01% 183
2018
Q2
$4K Hold
100
﹤0.01% 193
2018
Q1
$5K Hold
100
﹤0.01% 179
2017
Q4
$5K Hold
100
﹤0.01% 175
2017
Q3
$5K Hold
100
﹤0.01% 167
2017
Q2
$4K Hold
100
﹤0.01% 170
2017
Q1
$4K Sell
100
-100
-50% -$3.01K ﹤0.01% 174
2016
Q4
$4K Hold
200
﹤0.01% 172
2016
Q3
$3K Hold
200
﹤0.01% 220
2016
Q2
$2K Hold
200
﹤0.01% 206
2016
Q1
$1K Hold
200
﹤0.01% 213
2015
Q4
$1K Hold
200
﹤0.01% 214
2015
Q3
$1K Buy
+200
New +$2.09K ﹤0.01% 225

Other funds holding CC

Cowen Prime Advisors's CC Position: Q2 2023 in Review

Cowen Prime Advisors held its Chemours (CC) position steady in Q2 2023 at 220 shares worth $8.12K. The position accounts for ﹤0.01% of the portfolio, ranked #171.

Cowen Prime Advisors first reported a position in CC in Q3 2015 and has held it in 16 quarters since. 476 funds tracked by Wall St. Rank hold CC as of Q2 2023.

  • Cowen Prime Advisors held 220 shares of Chemours worth $8.12K as of Q2 2023.
  • Cowen Prime Advisors left its Chemours share count unchanged in Q2 2023.
  • Chemours made up ﹤0.01% of Cowen Prime Advisors's portfolio in Q2 2023, its #171 holding.
  • Cowen Prime Advisors first reported a position in Chemours in Q3 2015 and has held it in 16 quarters since.
  • 476 funds tracked by Wall St. Rank held Chemours as of Q2 2023.

Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.